ovarian cancer phenotype

Aliases

ovarian cancers, ovaries

Related entities (3)

Mentioned in (103)

Papers in which this entity is mentioned.

• A guide to transcriptomic deconvolution in cancer. (2026)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
• Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. (2026)
• Chromosomal instability as a driver of cancer progression. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
• Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
• Principles and methods for transferring polygenic risk scores across global populations. (2024)
• Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
• Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. (2024)
• Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. (2024)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• ENPP1 Immunobiology as a Therapeutic Target. (2023)
• Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. (2023)
• A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. (2023)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
• Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. (2022)
• Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer. (2022)
• Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA. (2022)
• Variant interpretation using population databases: Lessons from gnomAD. (2022)
• Single-cell genomic variation induced by mutational processes in cancer. (2022)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• A practical guide to cancer subclonal reconstruction from DNA sequencing. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. (2021)
• Potential Role of S-Palmitoylation in Cancer Stem Cells of Lung Adenocarcinoma. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. (2021)
• Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs. (2020)
• Inferring structural variant cancer cell fraction. (2020)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• Pan-cancer landscape of homologous recombination deficiency. (2020)
• Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment. (2019)
• Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. (2019)
• Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
• Fast and robust deconvolution of tumor infiltrating lymphocyte from expression profiles using least trimmed squares. (2019)
• Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer. (2019)
• Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
• Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing (2019)
• Pan-cancer whole-genome analyses of metastatic solid tumours. (2019)
• Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
• The Immune Landscape of Cancer. (2018)
• Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. (2018)
• Patterns and mechanisms of structural variations in human cancer. (2018)
• Copy number signatures and mutational processes in ovarian carcinoma. (2018)
• Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
• OncoKB: A Precision Oncology Knowledge Base. (2017)
• SVclone: inferring structural variant cancer cell fraction (2017)
• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. (2017)
• Statistical algorithms improve accuracy of gene fusion detection. (2017)
• Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm. (2017)
• Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
• Copy-number signatures and mutational processes in ovarian carcinoma (2017)
• Fast and Accurate Genomic Analyses using Genome Graphs (2017)
• B lymphocytes and cancer: a love-hate relationship. (2016)
• Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
• Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• DGIdb 2.0: mining clinically relevant drug-gene interactions. (2016)
• Direct Transcriptional Effects of Apolipoprotein E. (2016)
• Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
• Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. (2015)
• Clock-like mutational processes in human somatic cells. (2015)
• Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. (2015)
• Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial. (2015)
• RADIA: RNA and DNA integrated analysis for somatic mutation detection. (2014)
• TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. (2014)
• The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. (2014)
• Inferring tumour purity and stromal and immune cell admixture from expression data. (2013)
• Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. (2013)
• Ewing sarcoma protein: a key player in human cancer. (2013)
• Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. (2013)
• Signatures of mutational processes in human cancer. (2013)
• Large-scale genotyping identifies 41 new loci associated with breast cancer risk. (2013)
• Mutational heterogeneity in cancer and the search for new cancer-associated genes. (2013)
• RNA splicing: a new player in the DNA damage response. (2013)
• Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
• Pan-cancer patterns of somatic copy number alteration. (2013)
• Absolute quantification of somatic DNA alterations in human cancer. (2012)
• Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. (2012)
• Regulation of cancer progression by β-endorphin neuron. (2012)
• VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (2012)
• Summarizing and correcting the GC content bias in high-throughput sequencing. (2012)
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. (2011)
• BRCA1 and BRCA2: different roles in a common pathway of genome protection. (2011)
• Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. (2011)
• Automated medical image segmentation techniques. (2010)
• TumorBoost: normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays. (2010)
• The role of puberty in the developing adolescent brain. (2010)
• Gene--environment-wide association studies: emerging approaches. (2010)
• Tackling the widespread and critical impact of batch effects in high-throughput data. (2010)
• BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. (2009)
• Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. (2009)
• Circulating microRNAs as stable blood-based markers for cancer detection. (2008)
• Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. (2008)
• Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. (2005)
• The endocrine system: alcohol alters critical hormonal balance. (1997)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.